Kidney disease treatment is undergoing a transformation, driven by exciting new research that reveals the protective power of semaglutide in patients with type 2 diabetes. Semaglutide, a medication ...

While treatments like regular dialysis or a kidney transplant are lifesaving, access to them is becoming increasingly ...

R1 Therapeutics is debuting with an oversubscribed $77.5 million series A financing aimed at advancing its first-in-class ...

Five-year recurrence-free rates of 89.4% and 83.9% indicate durable disease control after ProSense cryoablation in localized ...

When kidneys fail in the intensive care unit, the stakes couldn’t be higher. Patients often face two options: lifelong dialysis or death, with families watching helplessly as their loved ones fight ...

Kidney failure, also known as end-stage renal disease (ESRD), occurs when kidneys lose their ability to filter waste and excess fluids from the blood effectively. This serious condition affects ...

It is stationing nurses at hospitals to educate patients early on the treatment. Read more at straitstimes.com. Read more at ...

Investors had reservations about data for a drug that could compete with a candidate from Vertex in APOL1-mediated kidney ...

Kidney disease has long been considered a progressive and irreversible condition, where treatment focuses only on slowing decline rather than restoring lost function. However, a promising scientific ...

Dennis Moledina encountered a common problem during his training in nephrology, the specialty dedicated to kidney health.

SELECT was a large study focused on obesity and cardiovascular disease in people without type 2 diabetes, but it included ...

Lindsay Curtis is a health & medical writer in South Florida. She worked as a communications professional for health nonprofits and the University of Toronto’s Faculty of Medicine and Faculty of ...